GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inhalation Sciences Sweden AB (XSAT:ISAB) » Definitions » Return-on-Tangible-Asset

Inhalation Sciences Sweden AB (XSAT:ISAB) Return-on-Tangible-Asset : -102.25% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Inhalation Sciences Sweden AB Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Inhalation Sciences Sweden AB's annualized Net Income for the quarter that ended in Mar. 2025 was kr-9.00 Mil. Inhalation Sciences Sweden AB's average total tangible assets for the quarter that ended in Mar. 2025 was kr8.80 Mil. Therefore, Inhalation Sciences Sweden AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was -102.25%.

The historical rank and industry rank for Inhalation Sciences Sweden AB's Return-on-Tangible-Asset or its related term are showing as below:

XSAT:ISAB' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -91.05   Med: -47.6   Max: 59.86
Current: -55.75

During the past 10 years, Inhalation Sciences Sweden AB's highest Return-on-Tangible-Asset was 59.86%. The lowest was -91.05%. And the median was -47.60%.

XSAT:ISAB's Return-on-Tangible-Asset is ranked worse than
79.82% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -1.04 vs XSAT:ISAB: -55.75

Inhalation Sciences Sweden AB Return-on-Tangible-Asset Historical Data

The historical data trend for Inhalation Sciences Sweden AB's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inhalation Sciences Sweden AB Return-on-Tangible-Asset Chart

Inhalation Sciences Sweden AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.86 -90.91 -73.80 -35.43 -39.23

Inhalation Sciences Sweden AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.08 -25.22 -31.10 -86.75 -102.25

Competitive Comparison of Inhalation Sciences Sweden AB's Return-on-Tangible-Asset

For the Medical Devices subindustry, Inhalation Sciences Sweden AB's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inhalation Sciences Sweden AB's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inhalation Sciences Sweden AB's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Inhalation Sciences Sweden AB's Return-on-Tangible-Asset falls into.


;
;

Inhalation Sciences Sweden AB Return-on-Tangible-Asset Calculation

Inhalation Sciences Sweden AB's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-5.147/( (16.446+9.794)/ 2 )
=-5.147/13.12
=-39.23 %

Inhalation Sciences Sweden AB's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=-8.996/( (9.794+7.802)/ 2 )
=-8.996/8.798
=-102.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Inhalation Sciences Sweden AB  (XSAT:ISAB) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Inhalation Sciences Sweden AB Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Inhalation Sciences Sweden AB's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Inhalation Sciences Sweden AB Business Description

Traded in Other Exchanges
N/A
Address
Halsovagen 7, Huddinge, SWE, 141 57
Inhalation Sciences Sweden AB develops and commercializes patented lab instrument for inhalation research. Its products include PreciseInhale an advanced laboratory system used to measure inhaled particles and their effect on lungs, and LaminarPace tool for drying small amounts of the drug substance.

Inhalation Sciences Sweden AB Headlines

No Headlines